Data Privacy Compliant Validation of Health Insurance Claims Data: the IDOMENEO Approach

Abstract

Recently, health insurance claims have regained the attention of the scientific community as a source of real-world evidence in health care research and quality improvement. To date, very few studies are available which investigate the validity of health insurance claims; these may be affected by bias from several sources, such as possible upcoding of co-morbidities and complications for reimbursement advantages. The IDOMENEO study investigates the inpatient treatment of peripheral arterial disease (PAD) comprehensively using various data sources with a consortium involving experts from health care research and data privacy, a large health insurance fund, biostatisticians, jurists, and computer scientists. Prospective registry data were collected from 30–40 vascular centres in Germany using the GermanVasc registry. In addition, health insurance claims data were prospectively collected from BARMER, the second largest health insurance fund in Germany. The consortium is currently developing a data privacy compliant method of health insurance claims data validation, the methodological foundations of which are described here.

The Impact of Chronic Kidney Disease on Mid-Term Outcomes after Revascularisation of Peripheral Arterial Occlusive Disease: Results from a Prospective Cohort Study

“…This was a secondary analysis of a prospective longitudinal multicentre cohort study. The rationale and design of the GermanVasc registry study were already published and have been registered at Clinicaltrials.gov (NCT03098290) and the German Registry of Clinical Trials (DRKS00014649) [ 16 , 23 ]. The study was approved by the ethical committee at the medical association in Hamburg, Germany (PV5691) as well as 18 additional ethical committees in Germany.…”

“…The study was approved by the ethical committee at the medical association in Hamburg, Germany (PV5691) as well as 18 additional ethical committees in Germany. The European Union (EU) General Data Protection Regulation (GDPR) compliant GermanVasc registry platform was developed to follow the principles of privacy by design while collecting the personal and medical data relevant for the current study [ 23 , 24 , 25 ]. Results were reported using the STrengthening the Reporting of OBservational studies in Epidemiology (STROBE) statement [ 26 ].…”

“…The current study aimed to determine the independent impact of both CKD and end stage kidney disease (ESKD) on mid-term outcomes after revascularisation in patients with symptomatic PAOD using validated clinical data from the prospective GermanVasc cohort study (NCT03098290) [ 16 , 23 ].…”

Quality of care in surgical/interventional vascular medicine: what can routinely collected data from the insurance companies achieve?

“…Registry data can be used for the further validation of routinely collected data. One approach using modelbased validation and a second approach using stratification-based validation have been developed within the IDOMENEO study funded by the German Federal Joint Committee (Gemeinsamer Bundesausschuss [G-BA]) [12]. In the model-based approach, the data is hierarchically ordered according to the hospital treating the patient, i.e.…”

Das Qualitätssicherungs- und Deviceregister des Deutschen Instituts für Gefäßmedizinische Gesundheitsforschung der DGG im Zeitalter von COVID-19, Big Data und künstlicher Intelligenz

“…Hierbei wird auf die verschiedenen Konsensusverfahren der internationalen Registerkonsortien zu Erhebungsparametern Bezug genommen, die sich explizit mit Indikatoren der Ergebnisqualität beschäftigt haben (eine Erweiterung auf Behandlungen der Aorta und Carotis steht derzeit vor dem Abschluss) [16][17][18]. Technisch erfolgt der dauerhafte Einsatz der datenschutzkonformen und datensicheren Registerplattform, die im Rahmen der prospektiven GermanVasc-Kohortenstudie (NCT03098290, DRKS00014649) entwickelt und anschließend etabliert wurde und deren wissenschaftliche Nutzung bei der Behandlung der PAVK durch 18 positive Ethikvoten überprüft wurde (Ethikkommission der federführenden Ärztekammer Hamburg, PV5691) [19][20][21]. Damit greifen die verschiedenen Interessen ineinander bzw.…”